TEGRETOL-XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tegretol-xr, and when can generic versions of Tegretol-xr launch?
Tegretol-xr is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in TEGRETOL-XR is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tegretol-xr
A generic version of TEGRETOL-XR was approved as carbamazepine by TARO on October 3rd, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEGRETOL-XR?
- What are the global sales for TEGRETOL-XR?
- What is Average Wholesale Price for TEGRETOL-XR?
Summary for TEGRETOL-XR
![TEGRETOL-XR drug patent expirations Drug patent expirations by year for TEGRETOL-XR](/p/graph/s/t/TEGRETOL-XR-patent-expirations.png)
![Drug Prices for TEGRETOL-XR](/p/graph/drug-price/TEGRETOL-XR.png)
See drug prices for TEGRETOL-XR
![Drug Sales Revenue Trends for TEGRETOL-XR](/p/graph/drug-sales-revenues/TEGRETOL-XR.png)
Paragraph IV (Patent) Challenges for TEGRETOL-XR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TEGRETOL-XR | Extended-release Tablets | carbamazepine | 100 mg | 020234 | 1 | 2005-12-30 |
US Patents and Regulatory Information for TEGRETOL-XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-001 | Mar 25, 1996 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-002 | Mar 25, 1996 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-003 | Mar 25, 1996 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TEGRETOL-XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-003 | Mar 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-003 | Mar 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-001 | Mar 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-002 | Mar 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-002 | Mar 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TEGRETOL-XR
See the table below for patents covering TEGRETOL-XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | A199387 | ⤷ Sign Up | |
Japan | 2592460 | ⤷ Sign Up | |
Italy | 8748270 | ⤷ Sign Up | |
Sweden | 8703034 | ⤷ Sign Up | |
Denmark | 175497 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |